Thematic Take

Powered by

Christopher Papadopoullos, principal analyst at GlobalData

Foreword: A growing sense of urgency in ESG 

At GlobalData, we define a theme as any disruptive trend or technology that keeps a business leader awake at night. Companies that invest in the right themes become success stories. Those that miss the essential themes in their industry end up as failures. 

ESG is one of the most important themes of the decade. The Paris Agreement, the global agreement to limit global warming to 2°C above pre-industrial levels, has been signed by 195 countries, including the US and China. As part of the agreement, many signatories need to reduce their emissions to meet 2030 emissions targets, which is creating a growing sense of urgency as we move closer to the end of the decade.  

This pressure feeds through to corporates, which must now navigate mandatory sustainability reporting, new rules on environmental due diligence, emissions pricing, and financial incentives to use more sustainable sources of energy.  

Many major corporates are well ahead of the regulation and have already started investing in improving the environmental impact of their business. They are changing the way they manage environmental data so that they can bring it up to the robustness of regulated financial data. They are investing in technological solutions to reduce their carbon footprint and understand the emissions generated by their supply chain and use of their product or service. Many corporates are insisting that suppliers and key business partners have commitments to cut their emissions.  

Key to all of this is establishing the right governance structures early on to lay the foundations for long-term success. Developing and executing a successful ESG strategy is now going to require the involvement of more teams and senior figures. 

While ESG drives internal business transformation, companies need to rein in ESG-related marketing and external communications. Terms like ‘climate neutral’ and ‘eco-friendly’ now invite unwanted attention from regulators keen to crack down on greenwashing as well as the anti-ESG movement. The anti-ESG movement has become especially strong in the US, where ESG has become a hot political topic, and poses a risk to any company that pushes ESG in its marketing. 

Go to article: Home | Ireland – the jewel in the life sciences crown?Go to article: Editor's letterGo to article: ContentsGo to article: Formacoat Company InsightGo to article: FormacoatGo to article: BriefingGo to article: News in NumbersGo to article: Latest NewsGo to article: Latest DealsGo to article: Project UpdatesGo to article: Trends & InsightGo to article: Micro Crystal advertGo to article: In DepthGo to article: Ireland – the jewel in the life sciences crown? Go to article: Explainer: US Election 2024 -Biden’s healthcare outlook Go to article: Caresyntax gears up to grow digital surgery platform Go to article: FDA’s Final Rule on IVDs: a stop gap en route to the VALID Act? Go to article: NGS: the road to personalising cancer care Go to article: AI-powered precision medicine: transforming patient safety in healthcare Go to article: The MedTech Forum 2024: Stakeholders told to act now or lose out on elections Go to article: Thematic TakeGo to article: Thematic Take: contentsGo to article: Foreword: A growing sense of urgency in ESG Go to article: ESG 1.0 is over – get ready for ESG 2.0 Go to article: ESG becomes mandatory: how to prepareGo to article: Theme timeline: the past, present and future of ESG Go to article: Case study: Medtronic MiniMed extended infusion set a step forward for sustainability Go to article: GlobalData’s Christopher Papadopoullos on net-zero strategy for businesses Go to article: Latest news: ESG in healthcareGo to article: 38% of companies lack an ESG strategy – GlobalData survey Go to article: Bring your own device: How patients own tech is being used in clinical trialsGo to article: Another recall: does Philips have a quality control problem? Go to article: FemTech: the world’s largest ‘niche’ market Go to article: Are therapists safe from AI disruption? Go to article: Japanese patients among least empowered in the developed worldGo to article: Why has New Zealand U-turned on the world’s first smoking ban?Go to article: Why sustainability reporting standards must be simple, consistent and transparentGo to article: Deal activity related to ESG in the medical device industry since 2021  Go to article: Alleima Company InsightGo to article: AlleimaGo to article: Sponsored supplementsGo to article: ListingsGo to article: EventsGo to article: Innovation RankingsGo to article: Buyer's GuidesGo to article: Next issue